Molecular level: how the signal is interrupted
The action of the drugs begins with competitive binding to receptors. In cardiomyocytes, switching off β1-adrenoceptors halts a complex intracellular cascade. The enzyme adenylyl cyclase is blocked, causing a sharp drop in the concentration of cyclic AMP (cAMP). This prevents the activation of protein kinase A. As a result, significantly fewer calcium ions enter the muscle cell, which at the molecular level leads to a decrease in contraction force.
In parallel, the drugs affect the juxtaglomerular cells of the kidneys. Blockade of local receptors inhibits renin secretion, which naturally disrupts the formation of angiotensin II. It is this mechanism that makes a key contribution to the development of the hypotensive effect.
Cardiac effects and hemodynamics
The direct pharmacodynamic effect on the heart consists of several negative effects:
- Inotropic: the force of cardiac contractions is weakened.
- Chronotropic: heart rate is reduced due to the suppression of sinus node automatism.
- Dromotropic: impulse conduction through the atrioventricular node is depressed.
- Reduction of automatism: the activity of ectopic pacemaker foci, including the AV node and Purkinje fibers, is suppressed.
A systemic consequence of these changes is a drop in cardiac output and a decrease in overall heart work. A decrease in myocardial oxygen demand occurs—the baseline mechanism for the successful treatment of coronary artery disease and angina pectoris. It is important to note that direct dilation of the coronary vessels is not typical for most members of this group (nebivolol, which stimulates nitric oxide production, is the only exception).
The heart failure treatment paradox
At first glance, prescribing drugs with a negative inotropic effect for heart failure seems illogical. However, in practice, they demonstrate a "paradoxical" result: over time, the ejection fraction increases and the functional class of the disease reliably decreases.
This positive effect is due exclusively to the blockade of β1-adrenoceptors. The drugs restore a delicate balance between oxygen delivery and consumption. Thanks to this, the contractile activity of so-called "sleeping" (hibernating) cardiomyocytes is restored. This approach is particularly effective when used in combination with ACE inhibitors.
Risks of non-selective blockade
If a drug lacks cardioselectivity and additionally blocks β2-adrenoceptors, undesirable systemic reactions occur. Smooth muscle tone increases in the airways, creating a real threat of bronchospasm. A spasm occurs in the peripheral vascular bed, leading to an increase in total peripheral vascular resistance (TPVR).
In addition, non-selective agents actively interfere with carbohydrate metabolism. They can reduce insulin secretion and mask the clinical symptoms of impending hypoglycemia, which requires extreme caution when prescribing them.
Use in ophthalmology
Beta-blockers are widely used as eye drops to lower intraocular pressure. For example, betaxolol (a selective β1-blocker) acts as a calcium channel blocker. It improves the microcirculation of the retina and optic nerve head, and also has a pronounced neuroprotective effect: by blocking calcium entry into the cell, it increases the resistance of ganglion cells to ischemia.
Timolol is also actively used (available preservative-free or as a single-use gel). It is often prescribed in combination with carbonic anhydrase inhibitors (e.g., Azarga, containing brinzolamide and timolol). Carbonic anhydrase inhibitors themselves lower intraocular pressure by inhibiting the enzyme of the same name in the ciliary body, which reduces the production of aqueous humor.
To easily memorize the intracellular cascade in the heart, learn the chain: Receptor → Adenylyl cyclase → cAMP → Protein Kinase A → Calcium. Blockade of the very first link breaks the entire chain, depriving the cardiomyocyte of the calcium required for a strong contraction.
Class and exam questions
How exactly do beta-blockers exert their antiarrhythmic effect?
The antiarrhythmic effect is achieved by reducing automatism, depressing conduction, and increasing the effective refractory period (ERP). It is important to understand that the decrease in myocardial contractility in this case is an accompanying side effect, not the mechanism for eliminating arrhythmia.
Do these drugs dilate coronary vessels during an anginal attack?
No, direct vasodilation is completely untypical for the overwhelming majority of beta-blockers. The antianginal effect is achieved solely through heart rate reduction and weakened contractions, which lowers the heart's oxygen demand. The only exception is nebivolol.
What is the danger of non-selective drugs for patients with carbohydrate metabolism disorders?
Blockade of β2-adrenoceptors leads to decreased insulin secretion and masks the autonomic symptoms of hypoglycemia. Because of this, the patient may not notice a critical drop in blood glucose levels.
What else to study on this topic
- Classification of beta-blockers: cardioselective and non-selective drugs
- Mechanism of action of carbonic anhydrase inhibitors (dorzolamide, brinzolamide)
- Features of using beta-blockers in combination with ACE inhibitors in heart failure
- Trade names and dosage forms of ophthalmic drugs (timolol, betaxolol)
- Neuroprotective effect of betaxolol in ganglion cell ischemia
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Full study guide on "Mechanism of action of beta-blockers" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Additional Topics" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.